Completed PHASE4 INTERVENTIONAL 2-arm NCT03866746

Aflibercept With and Without Micropulse Laser in Diabetic Macular Edema (MPL)

Aflibercept With Adjuvant Micro-Pulsed Yellow Laser Versus Aflibercept Monotherapy in Treatment of Diabetic Macular Edema.

Sponsor: Al Hadi Hospital

Conditions Diabetic Macular Edema

Interventions Aflibercept Injection micropulsed yellow laser

Updated 6 times since 2019 Last updated: Jul 2, 2019 Started: May 8, 2017 Primary completion: Jun 21, 2017 Completion: Dec 28, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Diabetic Macular Edema, this trial is completed. The trial is conducted by Al Hadi Hospital and has accumulated 6 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Aug 2019 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Apr 2019 — Aug 2019 [monthly]

Completed PHASE4

First recorded

May 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Al Hadi Hospital

Data source: Al Hadi Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hawalli, Kuwait